Red-Cell Aplasia, Pure [clinicaltrials_resource:ce4a95f63236442e4f47098fd398a2f1]
Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders [clinicaltrials:NCT00005893]Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin [clinicaltrials:NCT00210951]A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins [clinicaltrials:NCT00211029]clinicaltrials:NCT00229619Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]
condition [clinicaltrials_vocabulary:condition]
clinicaltrials:NCT00001962clinicaltrials:NCT00004143Stem Cell Transplantation (SCT) for Genetic Diseases [clinicaltrials:NCT00004378]Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders [clinicaltrials:NCT00005893]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin [clinicaltrials:NCT00210951]A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins [clinicaltrials:NCT00211029]A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment [clinicaltrials:NCT00211042]clinicaltrials:NCT00211068clinicaltrials:NCT00229619Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease [clinicaltrials:NCT00314795]Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00391287clinicaltrials:NCT01362595
condition browse [clinicaltrials_vocabulary:condition-browse]
clinicaltrials:NCT00001962clinicaltrials:NCT00004143Stem Cell Transplantation (SCT) for Genetic Diseases [clinicaltrials:NCT00004378]Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders [clinicaltrials:NCT00005893]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin [clinicaltrials:NCT00210951]A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins [clinicaltrials:NCT00211029]A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment [clinicaltrials:NCT00211042]clinicaltrials:NCT00211068clinicaltrials:NCT00229619Efficacy and Safety of Peginesatide in the Treatment of Anemia in Patients With Chronic Kidney Disease [clinicaltrials:NCT00314795]Identifying Characteristics of Bone Marrow Failure Syndromes [clinicaltrials:NCT00315419]clinicaltrials:NCT00391287clinicaltrials:NCT01362595
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Red-Cell Aplasia, Pure [clinicaltrials_resource:ce4a95f63236442e4f47098fd398a2f1]
Bio2RDF identifier
ce4a95f63236442e4f47098fd398a2f1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:ce4a95f63236442e4f47098fd398a2f1
identifier
clinicaltrials_resource:ce4a95f63236442e4f47098fd398a2f1
title
Red-Cell Aplasia, Pure
@en
type
label
Red-Cell Aplasia, Pure [clinicaltrials_resource:ce4a95f63236442e4f47098fd398a2f1]
@en
Red-Cell Aplasia, Pure